Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical calcitriol and diclofenac for basal cell carcinoma
NL-OMON36360Phase 3Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of calcitriol and diclofenac in basal cell carcinoma (BCC) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Histologic biomarker expression change. Started Nov 2011; status: active, not recruiting.
02
Drugs
calcitrioldiclofenac
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NL-OMON36360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36360.